Texas Permanent School Fund Corp Sells 33,897 Shares of Colgate-Palmolive (NYSE:CL)

Texas Permanent School Fund Corp lessened its holdings in Colgate-Palmolive (NYSE:CL) by 19.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 136,084 shares of the company’s stock after selling 33,897 shares during the quarter. Texas Permanent School Fund Corp’s holdings in Colgate-Palmolive were worth $13,206,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in Colgate-Palmolive during the fourth quarter worth $731,843,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after purchasing an additional 8,933,912 shares during the last quarter. Swedbank AB acquired a new position in shares of Colgate-Palmolive in the first quarter valued at $286,370,000. Acadian Asset Management LLC increased its holdings in shares of Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after purchasing an additional 2,955,442 shares during the last quarter. Finally, Magellan Asset Management Ltd increased its holdings in shares of Colgate-Palmolive by 4,162.6% in the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock valued at $160,718,000 after purchasing an additional 1,968,988 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Down 0.7 %

Shares of NYSE CL opened at $107.11 on Tuesday. The company has a 50 day simple moving average of $101.30 and a 200 day simple moving average of $94.73. The firm has a market cap of $87.52 billion, a PE ratio of 33.90, a price-to-earnings-growth ratio of 3.78 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the business earned $0.77 EPS. On average, research analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Analyst Upgrades and Downgrades

CL has been the topic of several research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the company from $107.00 to $109.00 in a research note on Monday. Evercore ISI upped their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 10th. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the company from $103.00 to $95.00 in a research note on Wednesday, July 24th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $102.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.